Stock PTPI PETROS PHARMACEUTICALS
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Petros Pharmaceuticals

Equities

PTPI

US71678J2096

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
0.6142 USD +4.92% Intraday chart for Petros Pharmaceuticals +0.69% -56.44%
May. 29 Petros Pharmaceuticals Successfully Completes AI-Integrated Formative Human Factors Study Demonstrating Positive Interaction with Web App Designed for STENDRA(R) OTC Switch CI
May. 15 Petros Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Evolution of the average Target Price on Petros Pharmaceuticals

Price target over the last 5 years

History of analyst recommendation changes

11.YfktYFeNrhmpgLG16W1FEZK0i46QzNDqnI0ibsJ9t1Q.NINlJxbS42vE0IjG0DJ0aOD87ufZj526yv1EKLo3_mEskmkMNsSYf93D3g~28e58541198e99aafac75cbc4e64f54b

Analyst Recommendations on Petros Pharmaceuticals

Maxim Initiates Petros Pharma at Buy Rating With $4 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.6142 USD
Average target price
4 USD
Spread / Average Target
+551.25%
High Price Target
4 USD
Spread / Highest target
+551.25%
Low Price Target
4 USD
Spread / Lowest Target
+551.25%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Petros Pharmaceuticals

Maxim

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PTPI Stock
  4. Consensus Petros Pharmaceuticals